stockportfolio.pro
Incyte Corporation P/E Ratio 2009–2025
Incyte Corporation (INCY) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -28.9%/yr over 16 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 15.41 | -96.7% |
| FY 2024 | 460.47 | +1843.4% |
| FY 2023 | 23.69 | -55.2% |
| FY 2022 | 52.84 | +207.4% |
| FY 2021 | 17.19 | — |
| FY 2020 | — | — |
| FY 2019 | 42.60 | -65.8% |
| FY 2018 | 124.69 | — |
| FY 2017 | — | — |
| FY 2016 | 185.69 | -94.9% |
| FY 2015 | 3615.00 | — |
| FY 2014 | — | — |
| FY 2013 | — | — |
| FY 2012 | — | — |
| FY 2011 | — | — |
| FY 2010 | — | — |
| FY 2009 | — | — |
Source: Incyte Corporation SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Incyte Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIncyte Corporation — frequently asked questions
What is Incyte Corporation's price-to-earnings ratio?
Incyte Corporation (INCY) reported price-to-earnings ratio of 15.41 for fiscal year 2025, per its SEC filings.
How has Incyte Corporation's price-to-earnings ratio changed over time?
Between fiscal 2009 and 2025, INCY's price-to-earnings ratio declined at roughly 28.9% per year (compound annual rate), from 3615.00 to 15.41.
Where does this data come from?
Figures are computed from Incyte Corporation's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.